Doctor profile · Federal record

Dr. Jeffrey Young, M.D.

Dermatology Physician (CMS: Dermatology) · Specialist · Specialist · Texarkana, TX

  • NPI 1215934062
  • Accepts Medicare
  • MIPS 85.7 / 100 · 2023
  • 32 yrs in practice
  • Licensed in 3 states
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2011 Moores Ln
Texarkana, TX 755031841
(903) 792-2777
fax (903) 794-6728

Credentials & registration

NPPES · NUCC
NPI registered
July 2005 — 21 yrs on file
Profile last updated
June 12, 2024
Year of graduation
1994 — 32 yrs since
Specialty taxonomy
207N00000X — NUCC code
State licenses (3)
Texas #K5033 · Arkansas #E2607 · Oklahoma #20679
Medicaid (2)
TX #031075701 · AR #134647001

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1215934062. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
13,195
Distinct HCPCS
10
Medicare allowed
$807,203
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 4,906 926 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 2,824 1,914 $87
17000 Destruction of precancer skin growth, 1 growth 1,731 1,284 $56
99214 Established patient office or other outpatient visit, 30-39 minutes 791 620 $124
99203 New patient office or other outpatient visit, 30-44 minutes 778 778 $108
11102 Biopsy of related skin growth, first growth 517 477 $92
88331 Pathology examination of specimen during surgery, first tissue block 328 291 $100
17110 Destruction of skin growth, 1-14 growths 234 211 $107
17281 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm 147 125 $167
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm 108 101 $165

In context: peer comparison

Among 2 peers in this city , average services per provider: 316. This provider delivers 42× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,148
Transactions
169
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 39 $635.42
Janssen Biotech, Inc. 19 $421.53
Novartis Pharmaceuticals Corporation 17 $403.68
Regeneron Healthcare Solutions, Inc. 8 $240.21
Lilly USA, LLC 11 $208.74
SUN PHARMACEUTICAL INDUSTRIES INC. 10 $181.66
E.R. Squibb & Sons, L.L.C. 14 $179.73
Journey Medical Corporation 10 $170.15
Dermavant Sciences, Inc. 12 $149.17
Arcutis Biotherapeutics, Inc. 9 $133.34
Amgen Inc. 5 $110.65
PFIZER INC. 6 $99.65
Ortho Dermatologics, a division of Bausch Health US, LLC 5 $97.37
Almirall LLC 2 $39.74
UCB, Inc. 2 $33.44

By nature of payment

Food and Beverage
$3,044
Education
$103

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,658
Patients
1,432
Total drug cost
$57,768
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 956 573 $9,021
Ketoconazole Generic 191 101 $5,098
Minocycline Hcl Generic 183 73 $6,572
Fluconazole Generic 169 83 $2,043
Fluocinonide Generic 152 90 $6,797
Hydroxyzine Hcl Generic 142 71 $1,951
Ciclopirox (Ciclopirox Olamine) Brand 138 77 $3,079
Spironolactone Generic 133 38 $1,706
Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) Brand 116 69 $4,872
Mometasone Furoate Generic 109 55 $2,034

Frequently asked questions

Auto-generated from federal data
What is Dr. Jeffrey Young's medical specialty?
Dr. Jeffrey Young practices Dermatology Physician in Texarkana, TX.
Where does Dr. Jeffrey Young practice?
Dr. Jeffrey Young practices at 2011 Moores Ln, Texarkana, TX 755031841. Office phone: 9037922777.
What is Dr. Jeffrey Young's NPI?
Dr. Jeffrey Young's National Provider Identifier (NPI) is 1215934062, issued by NPPES.
Does Dr. Jeffrey Young accept Medicare assignment?
Yes. Dr. Jeffrey Young accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jeffrey Young commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.